Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Amoxicillin 500mg powder for solution for injection vials
0501013C0AAADAD
|
Amoxicillin sodium | Amoxicillin sodium | Infections | 11 |
|
Ceftazidime 2g powder for solution for injection vials
0501021H0AAACAC
|
Ceftazidime pentahydrate | Ceftazidime pentahydrate | Infections | 11 |
|
Chloramphenicol 250mg capsules
0501070F0AAAAAA
|
Chloramphenicol (Systemic) | Chloramphenicol | Infections | 11 |
|
Lagevrio 200mg capsules
0503060A0BBAAAA
|
Lagevrio | Molnupiravir | Infections | 11 |
|
Biktarvy 50mg/200mg/25mg tablets
0503010AQBBAAAA
|
Biktarvy | Bictegravir/emtricitabine/tenofovir alafenamide | Infections | 10 |
|
Emtricitabine 200mg / Tenofovir disoproxil 245mg tablets
0503010AAAAAAAA
|
Emtricitabine/tenofovir disoproxil | Emtricitabine and tenofovir disoproxil | Infections | 10 |
|
Famvir 500mg tablets
0503021E0BBADAD
|
Famvir | Famciclovir | Infections | 10 |
|
Gentamicin 20mg/2ml solution for injection vials
0501040H0AAAEAE
|
Gentamicin sulfate (Systemic) | Gentamicin sulfate | Infections | 10 |
|
VFEND 200mg tablets
0502010D0BBAAAA
|
VFEND | Voriconazole | Infections | 10 |
|
Ceftriaxone 250mg powder for solution for injection vials
0501021G0AAABAB
|
Ceftriaxone sodium | Ceftriaxone sodium | Infections | 9 |
|
Descovy 200mg/25mg tablets
0503010AMBBABAB
|
Descovy | Emtricitabine and tenofovir alafenamide | Infections | 9 |
|
Imunovir 500mg tablets
0503021D0BBAAAA
|
Imunovir | Inosine pranobex | Infections | 9 |
|
Isoniazid 50mg/5ml oral solution
0501090K0AACUCU
|
Isoniazid (Systemic) | Isoniazid | Infections | 9 |
|
Klaricid Paediatric 125mg/5ml oral suspension
0501050B0BBABAB
|
Klaricid | Clarithromycin | Infections | 9 |
|
Raltegravir 400mg tablets
0503010AEAAAAAA
|
Raltegravir | Raltegravir | Infections | 9 |
|
Adefovir 10mg tablets
0503031A0AAAAAA
|
Adefovir dipivoxil | Adefovir dipivoxil | Infections | 8 |
|
Cefixime 400mg tablets
0501021C0AAACAC
|
Cefixime | Cefixime | Infections | 8 |
|
Cidomycin Adult Injectable 80mg/2ml inj vials
0501040H0BBAFAM
|
Cidomycin (Systemic) | Gentamicin sulfate | Infections | 8 |
|
Oseltamivir 45mg capsules
0503040B0AAADAD
|
Oseltamivir phosphate | Oseltamivir phosphate | Infections | 8 |
|
Benzylpenicillin sodium 1.2g inj vials
0501011J0AAAFAF
|
Benzylpenicillin sodium (Penicillin G) | Benzylpenicillin sodium (Penicillin G) | Infections | 7 |
|
Colobreathe 1,662,500unit inhalation powder capsules
0501070I0BDAAAG
|
Colobreathe | Colistimethate sodium | Infections | 7 |
|
Entecavir 50micrograms/ml oral solution sugar free
0503031B0AAACAC
|
Entecavir | Entecavir | Infections | 7 |
|
Erythroped A 500mg tablets
0501050H0BDAIAE
|
Erythroped | Erythromycin ethylsuccinate | Infections | 7 |
|
Isavuconazole 100mg capsules
0502010E0AAAAAA
|
Isavuconazole | Isavuconazole | Infections | 7 |
|
Minocycline 50mg capsules
0501030P0AAADAD
|
Minocycline hydrochloride (Systemic) | Minocycline hydrochloride | Infections | 7 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.